Fifth vaccine set to enter Phase III clinical trials
A fifth COVID-19 vaccine is scheduled to enter a Phase III clinical trial in the coming weeks with 30,000 participants in the United States and Mexico. Read More »
Vaccination efforts for frontline health care workers underway following Pfizer vaccine approval
The Food and Drug Administration Advisory panel approved the Pfizer-BioNTech COVID-19 vaccine Dec. 10, greenlighting vaccination efforts for priority groups including frontline health care workers, pharmacists and residents at long-term care facilities, the American Pharmacists Association reports. Read More »
PTCB: Pharmacy Technician Certification Board (PTCB) Rolls Out Advanced Certification for Experienced Pharmacy Technicians Who Have Comprehensive Knowledge and Skills
Newly launched CPhT-Adv credential supports the expanded roles of the most valuable players on the pharmacy team Read More »
AZD1222 vaccine meets base requirements in efficacy for preventing, treating COVID-19
The AZD1222 COVID-19 vaccine has shown positive early results, according to Astra Zeneca. Read More »
endpoint and McCreadie Group Software Integration Reduces Drug Speed to Market and Streamlines Research Pharmacy Workflows
endpoint Clinical, the leading global interactive response technology (IRT®) company, and McCreadie Group, the market leader in automating manual processes in Investigational Drug Services (IDS), have collaborated to increase study product accountability transparency for study sponsors, reduce site burdens associated with clinical study IMP management, and improve related data integrity via carefully balanced interfacing of McCreadie's site-based Vestigo® application and endpoint's PULSE® IRT. Read More »
RX SAVINGS SOLUTIONS: Provides Medicare Advantage Plans With Pharmacy Transparency
Tool builds trust, creates an enhanced member experience Read More »
FDA approves over-the-counter head lice lotion
The U.S. Food and Drug Administration (FDA) approved the over-the-counter (OTC) use of a lotion designed to treat head lice. Read More »
Pharmaceutical companies hope to bolster confidence in COVID-19 vaccine
While there are concerns about the unforeseen health impacts of a vaccine for COVID-19, a coalition of pharmaceutical companies has joined together to build confidence in the process and end result. Read More »
Pharmacists may qualify for NIH student loan repayments up to $100,000
The National Institute of Health (NIH) has recently expanded options for pharmacists to engage in their Loan Repayment Programs (LRPs), and can apply by Friday, Nov. 20 for this year’s programs. Read More »
DIGITAL PHARMACIST: Transforms Patient Communications With Launch of Rx Confer
Digital Pharmacist's new Rx Confer platform drives revenue for pharmacies while increasing the effectiveness of patient communications. Read More »
FDA approves drug combination that treats mesothelioma
The U.S. Food and Drug Administration (FDA) announced the approval of Opdivo (nivolumab) combined with Yervoy (ipilimumab) for first-line treatment of adults who have malignant pleural mesothelioma that cannot use alternative methods for removal such as surgery. Read More »
FDA approves use of XELJANZ on children
The U.S. Food and Drug Administration (FDA) recently approved Pfizer’s drug XELJANZ (tofacitinib) for treatment of polyarticular course juvenile idiopathic arthritis (pcJIA). Read More »
Trial shows promise for Eli Lilly-developed breast cancer treatment
Eli Lilly and Company’s phase 3 monarchE trial of their cancer treatment drug Verzenio® (abemaciclib) has demonstrated a significant decrease risk of breast cancer recurrence for patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) high risk early breast cancer. Read More »
PhRMA against 'most favored' nation policy
Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl has issued a statement regarding the administration's choice of the most favored nation policy. Read More »
Biopharmaceutical industry confident in COVID-19 vaccine, researchers say
Pharmaceutical Research and Manufacturers of America President and CEO Stephen Ubl said the biopharmaceutical industry is confident it will beat COVID-19 as it ensures the highest standards in research, testing and manufacturing a vaccine for the virus. Read More »
PhRMA exec optimistic on COVID-19 vaccine
The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »
John Hopkins study seeks solution for cardiovascular complications of people living with HIV
A recent pilot study conducted by Johns Hopkins Medicine may show promise for lowering cholesterol in some patients by using a drug that inhibits a protein involved in cholesterol metabolism. Read More »
AEI expert calls for coordinated world effort to distribute COVID-19 vaccine
James Capretta, a resident fellow and health analyst with the American Enterprise Institute (AEI), a Washington D.C.-based think tank that researches government, economics and social welfare, called for a coordinated effort to distribute vaccine worldwide to prevent COVID-19 infection. Read More »
Biopharmaceutical industry reports over 400 medicines, vaccines in development
A recent report by the biopharmaceutical industry shows that there are over 400 medicines and vaccines in development to treat infectious diseases, including COVID-19, according to a news release by PhRMA. Read More »
APHENA PHARMA SOLUTIONS: Unveils New Website
New Site Features More Information, Improved User Experience Read More »
Alerts Sign-up